base metals investing Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
base metals investing Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease
base metals investing Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease
base metals investing Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025
base metals investing Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights
base metals investing Biomea Fusion Announces First Patient Dosed in Phase I Study of BMF-650 a Next-Generation Oral GLP-1 Receptor Agonist
base metals investing Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series
base metals investing Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations
Metalsource Mining Strengthens Strategic Communications and Market Awareness as Exploration Advances at America's First Silver Mine
Sun Summit Commences Fully Funded 10,000 Meter Drill Program at the JD Project, Toodoggone Mining District, B.C.
